BPC-157 is believed to accelerate bodily repair through enhanced fibroblast proliferation and collagen synthesis, according to the National Institute of Health, when reviewing existing studies in August of 2025
As emphasized above, introduced as native peptide therapy, stable gastric pentadecapeptide BPC 157 therapy shared muscle healing and function restoration [11,12,13,14], largely involving striated, smooth, and heart muscle [11,12], enables the recovery of various junctions under the simultaneous healing of different particular tissues [11,12,13,14,24,25], along with other reported large beneficial effects [24,25], such as recovery of various junctions as simultaneous healing of different particular tissues [11,12,13,14,24,25]
There are no Therapeutic Use Exemptions (TUEs) for BPC-157, and its presence in an athletes system can lead to disqualification
Next Steps: Data Gaps: Clinical human safety data is currently limited to retrospective studies (e.g., sample size of 12) Nih
